How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?
- PMID: 39083709
- DOI: 10.1200/JCO.24.00566
How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous